Characteristic | HA | PRP | PRP + HA | |
---|---|---|---|---|
Number | 29 | 32 | 31 | |
Baseline Characteristics | ||||
 Age (y), Mean ± SD | 60.93 ± 4.54 | 58.22 ± 5.10 | 60.29 ± 4.83 | |
 Sex (male/female), # | 7/22 | 10/22 | 8/23 | |
 Hip OA grade (2/3), # | 16/13 | 16/16 | 17/14 | |
 Involved hip (right/left), # | 12/17 | 20/12 | 17/14 | |
 Pain duration (month), Mean ± SD | 3.43 ± 1.53 | 4.63 ± 2.50 | 4.26 ± 2.03 | |
 Height (m), Mean ± SD | 1.65 ± 0.08 | 1.67 ± 0.10 | 1.65 ± 0.09 | |
 Weight (kg), Mean ± SD | 74.93 ± 6.30 | 77.63 ± 10.05 | 76.03 ± 8.36 | |
 BMI (kg/m2), Mean ± SD | 27.62 ± 2.25 | 27.72 ± 2.11 | 27.94 ± 2.80 | |
 CBC | Hb (g/dL), Mean ± SD | 14.3 ± 1.52 | 13.59 ± 1.78 | 13.54 ± 1.70 |
WBC, (× 103/μL), Mean ± SD | 6.34 ± 1.40 | 6.45 ± 1.12 | 6.23 ± 1.07 | |
PLT, (× 103/μL), Mean ± SD | 269.51 ± 61.07 | 246.90 ± 9.25 | 235.83 ± 47.93 | |
 History of physiotherapy (> 1 month) (yes/no), # | 13/16 | 23/9 | 18/3 | |
 History of previous injection (> 6 months) (No/PRP/HA/CS), # | 21/2/5/1 | 16/7/6/3 | 18/6/5/2 | |
Outcome Measures,Mean ± SD | ||||
 WOMAC | Pain | 9.28 ± 1.41 | 9.53 ± 1.72 | 9.68 ± 1.49 |
Stiffness | 2.38 ± 1.21 | 2.75 ± 1.83 | 2.71 ± 1.01 | |
Function | 30.41 ± 8.72 | 29.09 ± 7.09 | 28.77 ± 6.84 | |
Total | 41.41 ± 11.52 | 41.38 ± 9.36 | 41.16 ± 8.13 | |
 VAS | 8.10 ± 1.18 | 7.63 ± 1.31 | 8.00 ± 1.18 | |
  Lequesne | Pain | 5.45 ± 1.02 | 4.91 ± 1.25 | 5.16 ± 1.10 |
MDW | 1.79 ± 1.05 | 1.56 ± 0.67 | 1.55 ± 0.57 | |
ADL | 5.59 ± 0.71 | 5.63 ± 0.76 | 5.74 ± 0.67 | |
Total | 12.52 ± 2.34 | 12.20 ± 2.18 | 12.45 ± 1.66 |